The role of previous radical local treatment (RLT) on the outcome of immune checkpoint inhibitors (ICI) in patients (pts) with metastatic urothelial carcinoma (mUC)

被引：0
|
作者：
Morales-Barrera, Rafael
Vidal Casinello, Natalia
Domenech, Montserrat
Bonfill, Teresa
Puente, Javier
Figols, Mariona
Giner Joaquin, Julia
Gonzalez, Macarena
Lozano, Fernando
Lopez, Hector
Galante, Isabel
Mast, Richard
Serra Hernandez, Ester
Eugenia Semidey, Maria
Serrano, Cesar
Gallardo Diaz, Enrique
Suarez Rodriguez, Cristina
Maldonado, Xavier
Morote, Juan
Carles, Joan
机构：
[1] Vall Hebron Inst, Barcelona, Spain
[2] Hosp Clin San Carlos, Madrid, Spain
[3] Hosp Althaia, Manresa, Spain
[4] Autonomous Univ Barcelona, Parc Tauli Univ Hosp, Parc Tauli Inst Res & Innovat I3PT, Sabadell, Spain
[5] Hosp Univ Clin San Carlos, Madrid, Spain
[6] Hosp Parc Tauli, Sabadell, Spain
[7] Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Vall Hebron Inst Oncol, Barcelona, Spain
[8] Vall Hebron Univ Hosp, Barcelona, Spain
[9] Hosp San Joan de Deu, Urol Dept, Manresa, Spain
[10] VHIO, Barcelona, Spain
[11] Hosp Univ Parc Tauli, Barcelona, Spain
[12] Univ Autonoma Barcelona, Vall Hebron Inst Oncol, Barcelona, Spain
[13] Vall Hebron Univ Hosp, Dept Urol, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
496
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Immunological correlates of response to immune checkpoint inhibitors (ICI) in metastatic urothelial carcinoma (mUC) patients (pts)
    Tzeng, Alice
    Diaz-Montero, C. Marcela
    Rayman, Patricia A.
    Kim, Jin Sub
    Pavicic, Paul G.
    Finke, James
    Barata, Pedro C.
    Lamenza, Marcelo
    Devonshire, Sarah
    Schach, Kim
    Emamekhoo, Hamid
    Ernstoff, Marc S.
    Hoimes, Christopher J.
    Rini, Brian I.
    Garcia, Jorge A.
    Gilligan, Timothy D.
    Ornstein, Moshe Chaim
    Grivas, Petros
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [2] Treatment and outcome after Immune checkpoint inhibitors (ICI) in metastatic Urothelial Carcinoma (mUC): A European perspective
    Lista, A. Gomez de Liano
    Necchi, A.
    Lavaud, P.
    Carles Galceran, J.
    Castellano, D.
    Ravaud, A.
    Duran, I.
    van Dijk, N.
    Giannatempo, P.
    Loriot, Y.
    Morales Barrera, R.
    De Velasco Oria De Rueda, G.
    Lefort, F.
    Martinez Bernal, G.
    Raggi, D.
    Gross-Goupil, M.
    Powles, T.
    van der Heijden, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [3] Effect of concurrent proton pump inhibitors (PPI) use in patients (pts) treated with immune checkpoint inhibitors (ICI) for metastatic urothelial carcinoma (mUC)
    Morales-Barrera, Rafael
    Vidal Casinello, Natalia
    Bonfill, Teresa
    Domenech, Montserrat
    Suarez Rodriguez, Cristina
    Puente, Javier
    Giner Joaquin, Julia
    Figols, Mariona
    Galante, Isabel
    Carrion, Albert
    Lopez, Hector
    Gonzalez, Macarena
    Roche, Sarai
    Mateo, Joaquin
    Gallardo Diaz, Enrique
    Fernandez Saez, Carlos
    Valverde Morales, Claudia Maria
    de Torres, Ines
    Morote, Juan
    Carles, Joan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [4] Local treatment on the outcome of immune-checkpoint inhibitors in metastatic urothelial carcinoma
    Maldonado, J.
    Morales Barrera, R.
    Vidal, N.
    Feltes, N.
    Domenech, M.
    Puente, J.
    Figols, M.
    Gonzalez, M.
    Lozano, F.
    Lopez, H.
    Gallardo, E.
    Moreno, D.
    Suarez, C.
    Morote, J.
    Carles, J.
    Giralt, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S637 - S638
  • [5] Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
    Reyes, Kevin R.
    Zhang, Li
    Zhu, Xiaolin
    Jindal, Tanya
    Deshmukh, Prianka
    de Kouchkovsky, Ivan
    Kumar, Vipul
    Maldonado, Edward
    Kwon, Daniel H.
    Chan, Emily
    Porten, Sima P.
    Borno, Hala
    Bose, Rohit
    Desai, Arpita
    Aggarwal, Rahul Raj
    Small, Eric Jay
    Fong, Lawrence
    Chou, Jonathan
    Friedlander, Terence W.
    Koshkin, Vadim S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [6] Characterizing immune-genomic signatures associated with response to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC)
    Pramod, Nikhil
    Dawsey, Scott
    Pavicic, Paul G.
    Lodha, Roshan
    Patgunarajah, Ubenthira
    Nair, Monica
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Wee, Christopher Eing
    Mian, Omar Y.
    Nizam, Amanda
    Nguyen, Jane
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Immunological correlates of response and immune-mediated toxicity in checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts).
    Nizam, Amanda
    Tzeng, Alice
    Wei, Wei
    Rayman, Patricia A.
    Pavicic, Paul G.
    Makarov, Vladimir
    Juric, Ivan
    Alban, Tyler
    Swaidani, Shadi
    Sheng, Iris Yeong-Fung
    Gilligan, Timothy D.
    Gupta, Shilpa
    Diaz-Montero, C. Marcela
    Ornstein, Moshe Chaim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [8] Comprehensive metabolomic profiling of plasma from patients (pts) with metastatic urothelial carcinoma (mUC) receiving immune checkpoint inhibitors (ICI) or platinum-based chemotherapy (PBC).
    El Zarif, Talal
    Adib, Elio
    Clish, Clary
    Shukla, Sachet A.
    Freeman, Dory
    Thomas, Jonathan
    Ravi, Praful
    Tuff, Martha
    McGregor, Bradley Alexander
    Mantia, Charlene
    Ravi, Arvind
    Sonpavde, Guru P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [9] Outcomes with immune checkpoint inhibitors (ICI) in patients (pts) with MTAP alterations (alt) in advanced urothelial carcinoma (aUC).
    Talukder, Rafee
    Bakaloudi, Dimitra Rafailia
    Lin, Genevieve Ihsiu
    Enright, Tom
    Leary, Jacob Beck
    Makrakis, Dimitrios
    Tripathi, Nishita
    Agarwal, Neeraj
    Jindal, Tanya
    Koshkin, Vadim S.
    Brown, Jason R.
    Johnson, Jeffrey
    Zakharia, Yousef
    Park, Joseph J.
    Alva, Ajjai Shivaram
    Barrera, Rafael Morales
    Drakaki, Alexandra
    Barata, Pedro C.
    Khaki, Ali Raza
    Grivas, Petros
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Genomic correlates of response and resistance to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC) in a real-world setting.
    Pramod, Nikhil
    Makarov, Vladimir
    Dawsey, Scott
    Pavicic, Paul G.
    Patgunarajah, Ubenthira
    Nair, Monica
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Wee, Christopher Eing
    Nizam, Amanda
    Mian, Omar Y.
    Nguyen, Jane
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 670 - 670
12345